Literature DB >> 16285340

Elevated plasma concentrations of atrial and brain natriuretic peptide in type 1 diabetic subjects.

K McKenna1, D Smith, M Sherlock, K Moore, E O'Brien, W Tormey, C J Thompson.   

Abstract

BACKGROUND: The intravenous infusion of atrial (ANP) and brain (BNP) natriuretic peptides have been shown to increase urinary albumin excretion in type 1 diabetes. AIMS: To measure plasma ANP and BNP concentrations in patients with type 1 diabetes and to examine the parameters associated with elevated plasma concentrations. Methods We measured plasma ANP and BNP concentrations, UAER, HbA1C systolic blood pressure, and left ventricular mass index. Plasma ANP and BNP were also measured in non-diabetic control subjects for comparison.
RESULTS: Using multivariate regression analysis plasma ANP correlated positively with HbA1C (1.9 + 0.47, p = 0.0002), UAER (0.37 + 0.05, p = 0.00001), SBP (1.26 + 0.5, p = 0.01) and LVMI (00.46 + 0.25, p = 0.07). BNP was positively related with LVMI (0.95 + 0.4, p = 0.02), and UAER (0.56 + 0.08, p = 0.001).
CONCLUSIONS: Plasma concentrations of ANP and BNP are elevated in some patients with type 1 diabetes. Plasma ANP concentrations are closely related to UAER and elevated plasma concentrations are associated with poor glycaemic control and systemic hypertension. Plasma BNP concentration is related to LVMI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285340     DOI: 10.1007/bf03169149

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  24 in total

1.  Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus.

Authors:  K McKenna; D Smith; W Tormey; C J Thompson
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

2.  Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria.

Authors:  K McKenna; D Smith; P Barrett; A Glenn; C M Kesson; J Connell; C J Thompson
Journal:  Diabet Med       Date:  2000-03       Impact factor: 4.359

3.  Urinary immunoreactive brain natriuretic peptide in patients with renal disease.

Authors:  K Totsune; K Takahashi; F Satoh; M Sone; M Ohneda; C Satoh; O Murakami; T Mouri
Journal:  Regul Pept       Date:  1996-07-05

4.  Brain natriuretic peptide as a cardiac hormone in essential hypertension.

Authors:  M Kohno; T Horio; K Yokokawa; K Murakawa; K Yasunari; K Akioka; A Tahara; I Toda; K Takeuchi; N Kurihara
Journal:  Am J Med       Date:  1992-01       Impact factor: 4.965

5.  Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure.

Authors:  T G Yandle; A M Richards; A Gilbert; S Fisher; S Holmes; E A Espiner
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

6.  Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.

Authors:  R Zietse; F H Derkx; W Weimar; M A Schalekamp
Journal:  J Am Soc Nephrol       Date:  1995-06       Impact factor: 10.121

7.  Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus.

Authors:  G M Bell; R K Bernstein; J H Laragh; S A Atlas; G D James; M S Pecker; J E Sealey
Journal:  Clin Sci (Lond)       Date:  1989-08       Impact factor: 6.124

8.  Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations.

Authors:  A Tanabe; M Naruse; T Wasada; K Naruse; T Yoshimoto; Y Omori; H Demura
Journal:  Eur J Endocrinol       Date:  1995-06       Impact factor: 6.664

9.  Atrial natriuretic factor in various stages of diabetic nephropathy.

Authors:  P T Sawicki; L Heinemann; K Rave; A Hohmann; M Berger
Journal:  J Diabet Complications       Date:  1988 Oct-Dec

10.  Basal and stimulated plasma atrial natriuretic factor in patients with type 1 diabetes with and without nephropathy.

Authors:  J A McKnight; G Roberts; B Sheridan; P M Bell; A B Atkinson
Journal:  Diabet Med       Date:  1991-10       Impact factor: 4.359

View more
  2 in total

Review 1.  Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Authors:  Merlin C Thomas; Robert C Atkins
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control.

Authors:  Daniel P Jacobsen; Ragnhild Røysland; Heidi Strand; Kjartan Moe; Meryam Sugulle; Torbjørn Omland; Anne Cathrine Staff
Journal:  Acta Diabetol       Date:  2022-07-07       Impact factor: 4.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.